This biomarker, targets tumour protein 53‐induced nuclear protein 1 (TP53INP1) gene, and the upregulation led to augmented proliferation and tumorigenesis in PC [79, 80, 81]. Here, TP53INP1 is linked to pachyonychia congenita.